TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
Voltar para busca
Dado oficial do USPTO
M2GEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
70
Atualização mais recente
16/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
08/06/2007
Data de registro
27/07/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/10/2019
Última transação
16/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
07/03/2007
Primeiro uso no comércio
01/06/2010
Código do desenho
4
Tipo de titular
03
Localização do titular
Hudson, FL
Examinador
PRATER,JILL I
Unidade examinadora
M80
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
M2GEN, CORP.
M. C. (pessoa física)
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Representantes
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Providing an electronic database for the collection and storage of clinical and molecular data derived from a patientan electronic database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases
Classe 44
Providing a database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectivenessproviding data regarding tumor-specific molecular signatures; namelyproviding objective data on the effectiveness of a drug and/or diagnostic test; and namelyproviding evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes; collection and analysis of data services in the field of human clinical and molecular data for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseasesmatching particular patients to a particular drugtreatmenttherapy or clinical trial by the specific molecular signature of the patient; providing an Internet-accessible medical records portal for use by physicianspatients and researchers for the storage and accessibility of electronic data in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness
Publicações
Histórico de despachos e eventos da marca no USPTO.
70 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/10/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/10/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/10/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/09/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
14/08/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27/07/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
29/08/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
27/09/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
29/11/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
29/11/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/11/2016
E815
TEAS SECTION 8 & 15 RECEIVED
20/09/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
27/07/2010
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23/06/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
22/06/2010
ALIE
ASSIGNED TO LIE
22/06/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/06/2010
MNDA
NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
08/06/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/06/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/06/2010
EX3G
SOU EXTENSION 3 GRANTED
03/06/2010
DPCC
DIVISIONAL PROCESSING COMPLETE
03/06/2010
IUAF
USE AMENDMENT FILED
01/06/2010
EXT3
SOU EXTENSION 3 FILED
01/06/2010
DRRR
DIVISIONAL REQUEST RECEIVED
01/06/2010
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/06/2010
EEXT
SOU TEAS EXTENSION RECEIVED
01/06/2010
EISU
TEAS STATEMENT OF USE RECEIVED
01/06/2010
EX2G
SOU EXTENSION 2 GRANTED
25/01/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/01/2010
EXT2
SOU EXTENSION 2 FILED
10/12/2009
EEXT
SOU TEAS EXTENSION RECEIVED
10/12/2009
EX1G
SOU EXTENSION 1 GRANTED
17/07/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/07/2009
EXT1
SOU EXTENSION 1 FILED
25/06/2009
EEXT
SOU TEAS EXTENSION RECEIVED
25/06/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
06/01/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/11/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/11/2008
PUBO
PUBLISHED FOR OPPOSITION
14/10/2008
NPUB
NOTICE OF PUBLICATION
24/09/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/09/2008
CNEA
EXAMINERS AMENDMENT MAILED
25/08/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/08/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
25/08/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/08/2008
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
25/08/2008
ISSR
WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
15/08/2008
PUBO
PUBLISHED FOR OPPOSITION
12/08/2008
NPUB
NOTICE OF PUBLICATION
23/07/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/07/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/07/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/04/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/04/2008
CNRT
NON-FINAL ACTION MAILED
16/11/2007
CNRT
NON-FINAL ACTION WRITTEN
15/11/2007
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
13/11/2007
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
29/10/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
16/10/2007
ALIE
ASSIGNED TO LIE
16/10/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/09/2007
DOCK
ASSIGNED TO EXAMINER
16/09/2007
MAFR
APPLICATION FILING RECEIPT MAILED
19/06/2007
NWAP
NEW APPLICATION ENTERED
14/06/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace M2GEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.